| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |